Johns Hopkins Health System

Investment Strategy

Johns Hopkins Health System is a nonprofit academic health care system headquartered in Baltimore, Maryland, managing approximately $4 billion in endowment and investment assets. The health system is the clinical enterprise of Johns Hopkins Medicine, which also encompasses the Johns Hopkins University School of Medicine. The Johns Hopkins Hospital, which opened in 1889, is consistently ranked among the top hospitals in the United States and has been a pioneering institution in American medicine since its founding.

The health system’s endowment is distinct from The Johns Hopkins University endowment, which is managed separately. The health system’s investment assets support clinical operations, medical research, education, and capital investments across the Johns Hopkins Medicine enterprise. This enterprise includes The Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center, Suburban Hospital, Sibley Memorial Hospital, and the Johns Hopkins All Children’s Hospital, along with international affiliations.

The investment portfolio is diversified across public equities, fixed income, private equity, venture capital, hedge funds, and real estate. The portfolio is managed by an internal investment team under the direction of the health system’s investment committee. At $4 billion, the endowment is of sufficient scale to access institutional-quality investment opportunities across asset classes.

Johns Hopkins is one of the largest recipients of research funding from the National Institutes of Health, receiving over $2 billion annually in federal research grants. This research enterprise generates a significant pipeline of scientific discoveries and intellectual property, some of which reaches commercialization through Johns Hopkins Technology Ventures, the institution’s technology transfer office. The research environment provides the investment team with access to insights about emerging therapeutic areas and medical technologies.

Private Markets Approach

Johns Hopkins Health System allocates an estimated 30% of its endowment to alternative investments, including private equity, venture capital, hedge funds, and real estate. The alternatives allocation is designed to enhance long-term returns and provide diversification relative to the public markets portfolio.

The private equity program includes commitments to buyout, growth equity, and venture capital funds. Johns Hopkins’ standing as one of the world’s leading biomedical research institutions gives its investment team natural expertise in health care and life sciences investing. The institution’s researchers and clinicians are at the forefront of fields including oncology, neuroscience, immunology, and genomics, providing the investment team with informed perspectives on health care market developments.

Johns Hopkins Technology Ventures manages the institution’s technology commercialization activities, including licensing agreements, spinoff companies, and startup incubation. This institutional venture activity creates a pipeline of early-stage health care companies and provides the investment team with insight into the commercialization landscape, complementing external fund commitments.

The Baltimore-Washington corridor, where Johns Hopkins operates, is home to a growing biotech and health care technology ecosystem, supported by proximity to the NIH, the FDA, and numerous federal health agencies. This regional ecosystem provides additional context for the investment team’s evaluation of health care-related private markets opportunities.

Hedge fund allocations provide alternative return sources and risk management within the portfolio. Real estate investments complement the endowment’s diversification strategy, with particular relevance given the health system’s extensive campus infrastructure and ongoing facility development programs.

Fund managers seeking commitments should recognize Johns Hopkins’ deep institutional expertise in health care. Managers with health care, life sciences, or biotech strategies will find an informed audience, but the endowment is managed as a diversified portfolio, and strong managers across all sectors are relevant to the investment team’s mandate.